2023 - 2024 LEGISLATURE
May 25, 2023 - Introduced by Representatives Murphy, Cabrera, Drake, Ohnstad,
Rozar, Shankland, Sinicki and Clancy, cosponsored by Senators
Cabral-Guevara, Cowles, Roys and Spreitzer. Referred to Committee on
AJR49,1,2 1Relating to: designating Hypertrophic Cardiomyopathy Awareness Day and efforts
2to educate people about hypertrophic cardiomyopathy.
AJR49,1,63 Whereas, Hypertrophic Cardiomyopathy (HCM) is a chronic cardiovascular
4disease involving thickening of the heart muscle and can potentially lead to
5debilitating symptoms and serious complications including heart failure, atrial
6fibrillation, stroke, and in rare cases sudden cardiac death; and
AJR49,1,97 Whereas, HCM is the most common inheritable heart disease and can affect
8anyone regardless of age, gender, or ethnicity with a reported prevalence ranging
9from 1 in 200 to 1 in 500 in the general population; and
AJR49,1,1110 Whereas, an estimated 700,000 to 1,650,000 people in the United States have
11HCM, yet 85 percent of them may remain undiagnosed; and
AJR49,1,1412 Whereas, HCM shares symptoms with other common cardiovascular and
13pulmonary diseases, such as shortness of breath, chest pain, fatigue, palpitations,
14and fainting, making it difficult to distinguish HCM from these other diseases; and
1Whereas, all-cause mortality risk is three to four times higher in patients with
2HCM than that of the general population; and
AJR49,2,43 Whereas, knowing one's medical history and any signs and symptoms of HCM
4is an important first step in receiving an accurate diagnosis of HCM; and
AJR49,2,75 Whereas, a healthcare provider must conduct a thorough screening with
6cardiac health questions to help identify a risk of cardiac disorders both genetic and
7congenital; and
AJR49,2,108 Whereas, a health-care provider may conduct several tests, including an
9echocardiogram, a cardiac MRI, or genetic testing to confirm a family history of
10HCM, and must examine the heart to diagnose HCM; and
AJR49,2,1411 Whereas, following a diagnosis of HCM, it is important for patients to work with
12their healthcare provider to learn more about their disease and understand different
13management options, including prescription medicines and surgical treatment
14options that may help; and
AJR49,2,1615 Whereas, the fourth Wednesday in February is an appropriate day to observe
16Hypertrophic Cardiomyopathy Awareness Day; now, therefore, be it
AJR49,2,20 17Resolved by the assembly, the senate concurring, That the Wisconsin
18Legislature designates the fourth Wednesday in February of each year as
19“Hypertrophic Cardiomyopathy Awareness Day” in Wisconsin in order to raise public
20awareness about hypertrophic cardiomyopathy; and, be it further
AJR49,2,23 21Resolved, That the Wisconsin Legislature acknowledges the critical
22importance of hypertrophic cardiomyopathy awareness to improve cardiovascular
23health in Wisconsin; and, be it further
AJR49,3,2 24Resolved, That the Wisconsin Legislature supports raising awareness of the
25consequences of undiagnosed and untreated hypertrophic cardiomyopathy and the

1need to seek appropriate care for hypertrophic cardiomyopathy as a serious public
2health issue; and, be it further
AJR49,3,6 3Resolved, That the Wisconsin Legislature respectfully requests the Governor
4to issue annually a proclamation recognizing the fourth Wednesday in February in
5as “Hypertrophic Cardiomyopathy Awareness Day” in Wisconsin and calls upon the
6people in this state to observe the day with appropriate programs and activities.
AJR49,3,77 (End)